Mylatabi

Medicinal product

(Invented) name

Mylatabi

Active substance (s)

Eltrombopagas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX05, Eltrombopag

Marketing authorisation holder

UAB Brosfarma, Lietuva

Date of authorisation

2026-06-25

Date of renewal

Documents

3501_Mylatabi 25mg_pl_deng_tab_PZPL_2026-06-25.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Eltrombopagas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121426	107533	1107533	lizdinė plokštelė	N28		Receptinis	LT/L/26/3501/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-06-25	Registruotas